Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9719	Companies
193909	Keywords
125109	Articles
103195	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 10/10/2024 at 07:11, 1 year 3 months ago

Heidelberg Pharma AG's Interim Report for First Nine Months of 2024

Financial Report Heidelberg Pharma HDP-101 Trial Clinical Outcomes Royalty Sale
PRESS RELEASE

published on 10/10/2024 at 07:06, 1 year 3 months ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
Heidelberg Pharma AG provides insights on its operational progress and financial figures for the first nine months of fiscal year 2024. Development activities, new clinical data, R&D webinars, and guidance updates are highlighted

Financial Figures Clinical Data Heidelberg Pharma AG R&D Webinars Guidance Updates
BRIEF

published on 10/01/2024 at 17:34, 1 year 3 months ago

Heidelberg Pharma Presents Promising Clinical Data for Lead ADC Candidate HDP-101

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma ADC
PRESS RELEASE

published on 10/01/2024 at 17:29, 1 year 3 months ago

Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
Heidelberg Pharma presents new clinical data on lead ADC candidate HDP-101 at IMS 2024, showing complete remission in one patient. Company developing innovative ADCs for cancer treatment

Clinical Data Heidelberg Pharma ADC IMS 2024 Complete Remission
BRIEF

published on 10/01/2024 at 15:32, 1 year 3 months ago

Heidelberg Pharma AG Announces Updated Financial Guidance

Financial Year 2024 Heidelberg Pharma Operating Expenses Updated Guidance Cash Requirements
PRESS RELEASE

published on 10/01/2024 at 15:27, 1 year 3 months ago

EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance
Heidelberg Pharma AG adjusts its 2024 guidance, expecting sales and other income between EUR 10.0 - 12.0 million and operating expenses between EUR 30.0 - 33.0 million. The company anticipates secured financing until mid-2025

Financial Year Heidelberg Pharma AG Operating Expenses Updated Guidance Secured Financing
BRIEF

published on 09/23/2024 at 13:10, 1 year 3 months ago

Heidelberg Pharma to Present New Clinical Data on HDP-101 at IMS 2024

Clinical Data Heidelberg Pharma HDP-101 Multiple Myeloma IMS 2024
PRESS RELEASE

published on 09/23/2024 at 13:05, 1 year 3 months ago

Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
Heidelberg Pharma announces new clinical data on lead ATAC candidate HDP-101 to be presented at International Myeloma Society Annual Meeting 2024

Clinical Data Heidelberg Pharma HDP-101 ATAC Candidate Myeloma Society
BRIEF

published on 07/11/2024 at 07:10, 1 year 6 months ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business

Financial Results Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma
PRESS RELEASE

published on 07/11/2024 at 07:05, 1 year 6 months ago

Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation

Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation

Accesswire

Published on 01/22/2026 at 12:00, 31 minutes ago

Banyan Gold Intersects 10,734 g/t Silver Over 1.7m, Confirming Structure Hosting High Grade Keno-Style Mineralization, AurMac, Yukon, Canada
Published on 01/22/2026 at 11:00, 1 hour 31 minutes ago

Kingfisher Confirms Blind Copper-Gold Porphyry Discovery at Hank, HWY 37 Project, Golden Triangle, British Columbia
Published on 01/22/2026 at 09:01, 3 hours 30 minutes ago

Formation Metals to Commence Maiden Mineral Resource Estimate Inclusive of Nearly 70,000 Metres of Drilling Following Completion of Ongoing Phase 1 Drill Program at the Advanced N2 Gold Project
Published on 01/22/2026 at 05:25, 7 hours 6 minutes ago

Sceptre Ventures Announces 10-for-1 Share Consolidation and Non-Brokered Private Placement Offering
Published on 01/22/2026 at 00:00, 12 hours 31 minutes ago

Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services

View all ACCESSWIRE

EQS Group

Published on 01/22/2026 at 12:23, 8 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 01/22/2026 at 12:20, 11 minutes ago

Halfords Group PLC: Director/PDMR Shareholding
Published on 01/22/2026 at 11:45, 46 minutes ago

TradeInn Scales Global Operations: A Tech-Driven Powerhouse Reaching €585M in 2025
Published on 01/22/2026 at 11:05, 1 hour 26 minutes ago

VT Markets Publishes 2026 Outlook Report Highlighting Opportunities Amid Steady Growth
Published on 01/22/2026 at 11:00, 1 hour 31 minutes ago

ABB Ltd: ABB share buybacks - January 15, 2026 - January 21, 2026

Les Echos

Published on 01/22/2026 at 08:45, 3 hours 46 minutes ago

Air Liquide voluntary low-carbon electricity sourcing gains momentum, with 3 TWh per year of additional PPAs started in 2025
Published on 01/22/2026 at 08:29, 4 hours 2 minutes ago

bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies
Published on 01/22/2026 at 07:00, 5 hours 31 minutes ago

2025 sales: €918m at constant exchange rates (+4.3%) - €899m at current exchange rates (+2.1%)
Published on 01/21/2026 at 17:40, 18 hours 51 minutes ago

Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Published on 01/21/2026 at 08:45, 1 day 3 hours ago

ENGIE signs a 10-year Biomethane Purchase Agreement with PepsiCo, its first in the United Kingdom

View all LES ECHOS COMFI WIRE